File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Translational research in nasopharyngeal carcinoma

TitleTranslational research in nasopharyngeal carcinoma
Authors
Chiang, AKSMak, NKNg, WT
KeywordsNPC
EBV
Angiogenesis
Growth factor receptor
Targeted therapy
Issue Date2014
PublisherPergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology
Citation
Oral Oncology, 2014, v. 50 n. 5, p. 345-352 How to Cite?
DOI: http://dx.doi.org/10.1016/j.oraloncology.2013.11.005
AbstractNasopharyngeal carcinoma is well known to be a viral driven malignancy. Despite high loco-regional control rate with modern radiotherapy, distant metastasis remains as a major threat to the patients highlighting the importance of effective systemic therapy. Recent advances in the understanding of tumor biology, host cell–virus interaction and genetics have paved new ways for targeted therapies. This review summarizes the recent advances into our knowledge and understanding of NPC and highlights potential novel therapeutic strategies that may prove useful to treat this disease.
Persistent Identifierhttp://hdl.handle.net/10722/198063
ISSN
1368-8375
2021 Impact Factor: 5.972
2020 SCImago Journal Rankings: 1.623
ISI Accession Number ID
WOS:000334583600006

 

DC FieldValueLanguage
dc.contributor.authorChiang, AKS-
dc.contributor.authorMak, NK-
dc.contributor.authorNg, WT-
dc.date.accessioned2014-06-25T02:43:49Z-
dc.date.available2014-06-25T02:43:49Z-
dc.date.issued2014-
dc.identifier.citationOral Oncology, 2014, v. 50 n. 5, p. 345-352-
dc.identifier.issn1368-8375-
dc.identifier.urihttp://hdl.handle.net/10722/198063-
dc.description.abstractNasopharyngeal carcinoma is well known to be a viral driven malignancy. Despite high loco-regional control rate with modern radiotherapy, distant metastasis remains as a major threat to the patients highlighting the importance of effective systemic therapy. Recent advances in the understanding of tumor biology, host cell–virus interaction and genetics have paved new ways for targeted therapies. This review summarizes the recent advances into our knowledge and understanding of NPC and highlights potential novel therapeutic strategies that may prove useful to treat this disease.-
dc.languageeng-
dc.publisherPergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology-
dc.relation.ispartofOral Oncology-
dc.subjectNPC-
dc.subjectEBV-
dc.subjectAngiogenesis-
dc.subjectGrowth factor receptor-
dc.subjectTargeted therapy-
dc.titleTranslational research in nasopharyngeal carcinoma-
dc.typeArticle-
dc.identifier.emailChiang, AKS: chiangak@hku.hk-
dc.identifier.emailNg, WT: ngwt1@hkucc.hku.hk-
dc.identifier.authorityChiang, AKS=rp00403-
dc.identifier.authorityNg, WT=rp02671-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.oraloncology.2013.11.005-
dc.identifier.pmid24333100-
dc.identifier.scopuseid_2-s2.0-84898834624-
dc.identifier.hkuros229249-
dc.identifier.volume50-
dc.identifier.issue5-
dc.identifier.spage345-
dc.identifier.epage352-
dc.identifier.isiWOS:000334583600006-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1368-8375-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats